Because decreasing TYMS in response to EPE diversifies the effect of EMT in more invasive CRC cancer cells [9], the previously reported diminished mobility and invasive ability of MPM cells upon EPE treatment [14] is accomplished with TYMS downregulation as well. The gene discussed is TYMS; the disease is cancer.